Euglycemic Diabetic Ketoacidosis (EuDKA) SGLT2 Inhibitors Increasing Indications Significant Adverse Drug Effects Definition of EuDKA • Metabolic acidosis with pH < 7-3 • Decreased serum bicarbonate level < 18 mEq/L • Relatively low blood glucose level < 200 mg/dL Pathophysiology of EuDKA by Gillian Leung, PharmD @GillPillPharmD via @accpcardprn #Euglycemic #Diabetic #Ketoacidosis #EuDKA #diagnosis #management #endocrinology
